A population study of clinically actionable genetic variation affecting drug response from the Middle EastPuthen V. Jithesh, Stephan Lorenz, Mohammed El Anbari et al.|npj Genomic Medicine|2022Cited by 52
Analysis of 14,392 whole genomes reveals 3.5% of Qataris carry medically actionable variantsAmal Elfatih, Zohreh Tatari-Calderone, Chadi Saad et al.|European Journal of Human Genetics|2024Cited by 22